Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trial

Pomalidomide-dexamethasone in refractory multiple myeloma: Long-term follow-up of a multi-cohort phase II clinical trialLeukemia, Published online: 1 September 2017; doi:10.1038/leu.2017.258
Source: Leukemia - Category: Hematology Authors: Source Type: research